Skip to main content
Andrew Pavia, MD, Infectious Disease, Salt Lake City, UT, Primary Children's Hospital

AndrewT.PaviaMD

Infectious Disease Salt Lake City, UT

HIV/AIDS Medicine, Healthcare Associated Infections, Transplant/Immunocompromised States

Professor of Pediatrics and Adjunct Professor of Internal Medicine at University of Utah

Dr. Pavia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pavia's full profile

Already have an account?

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Infectious Disease, 1989 - 1990
  • Centers for Disease Control and Prevention
    Centers for Disease Control and PreventionResidency, Epidemic Intelligence Service, 1987 - 1989
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1981 - 1985
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 1981

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 1988 - 2026
  • NV State Medical License
    NV State Medical License 2016 - 2025
  • VT State Medical License
    VT State Medical License 1983 - 2000
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Authored Content

  • Rhinovirus in Febrile Infants and Risk of Bacterial InfectionFebruary 2018
  • Rhinovirus in Febrile Infants and Risk of Bacterial InfectionFebruary 2018
  • Rhinovirus in Febrile Infants and Risk of Bacterial InfectionJanuary 2018

Press Mentions

  • We’ll Soon Have Tools To Protect Infants Against RSV. Can We Put Them To Good Use?
    We’ll Soon Have Tools To Protect Infants Against RSV. Can We Put Them To Good Use?May 24th, 2023
  • End of PHE 'A Call to Arms' for Refining Disease Reporting, Experts Say
    End of PHE 'A Call to Arms' for Refining Disease Reporting, Experts SayMarch 23rd, 2023
  • Why COVID-19-Related Hospital Admissions Are Rising in Western States
    Why COVID-19-Related Hospital Admissions Are Rising in Western StatesMarch 3rd, 2023
  • Join now to see all

Grant Support

  • Tolerated Dose Of CI 1012 In LATE Stage HIV+ PatientsNational Center For Research Resources1999–2001

Professional Memberships

Hospital Affiliations